Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)
China
· Delayed Price · Currency is CNY 3.940
0.00 (0.00%)
May 16, 2025, 3:04 PM CST
SHE:002424 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 33.62 | -414.51 | 138.47 | 118.48 | 152.38 | Upgrade
|
| Depreciation & Amortization | - | 115.58 | 116.16 | 107.01 | 96.48 | Upgrade
|
| Other Amortization | - | 8.66 | 7.32 | 6.77 | 20.56 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -1.14 | 0.3 | 0.47 | -0.07 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | -0.15 | -0.9 | 0.92 | 0.49 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 4.3 | -38.73 | -58.53 | -36.34 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 70.23 | 60.47 | 66.48 | 100.94 | Upgrade
|
| Other Operating Activities | -24.6 | 151.18 | 138.73 | 104.78 | 134.39 | Upgrade
|
| Change in Accounts Receivable | - | -34.97 | -182.7 | 193.73 | -163.74 | Upgrade
|
| Change in Inventory | - | -396.58 | 8.74 | -70.21 | 221.06 | Upgrade
|
| Change in Accounts Payable | - | 734.65 | 220.91 | -95.77 | 33.31 | Upgrade
|
| Change in Other Net Operating Assets | - | - | 46.12 | -46.12 | - | Upgrade
|
| Operating Cash Flow | 9.02 | 125.77 | 502.15 | 324.92 | 544.41 | Upgrade
|
| Operating Cash Flow Growth | -92.83% | -74.95% | 54.55% | -40.32% | 16.47% | Upgrade
|
| Capital Expenditures | -42.02 | -104.12 | -68.45 | -425.73 | -90.02 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.06 | 1.46 | 0.78 | 0.12 | 0.15 | Upgrade
|
| Cash Acquisitions | - | -3.92 | - | - | - | Upgrade
|
| Divestitures | - | - | - | - | -31.4 | Upgrade
|
| Investment in Securities | 133.8 | 63.32 | 80.75 | -162.07 | 10.09 | Upgrade
|
| Other Investing Activities | -11.32 | 8.73 | 7.33 | 282.47 | -337.43 | Upgrade
|
| Investing Cash Flow | 80.52 | -34.83 | 20.44 | 42.59 | -517.37 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 1,546 | - | Upgrade
|
| Long-Term Debt Issued | 1,627 | 1,698 | 1,480 | 90 | 2,351 | Upgrade
|
| Total Debt Issued | 1,627 | 1,698 | 1,480 | 1,636 | 2,351 | Upgrade
|
| Long-Term Debt Repaid | -1,567 | -1,733 | -1,710 | -2,202 | -2,360 | Upgrade
|
| Total Debt Repaid | -1,567 | -1,733 | -1,710 | -2,202 | -2,360 | Upgrade
|
| Net Debt Issued (Repaid) | 59.93 | -34.69 | -229.73 | -566.01 | -9 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 82.9 | Upgrade
|
| Repurchase of Common Stock | - | -100.01 | - | -100.2 | - | Upgrade
|
| Common Dividends Paid | -81.35 | -80.54 | -86.55 | -100.18 | -431.57 | Upgrade
|
| Other Financing Activities | -147.62 | 0.43 | 1 | - | -53.7 | Upgrade
|
| Financing Cash Flow | -169.04 | -214.81 | -315.28 | -766.39 | -411.37 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | -0 | 0 | -0 | - | Upgrade
|
| Net Cash Flow | -79.5 | -123.87 | 207.31 | -398.89 | -384.33 | Upgrade
|
| Free Cash Flow | -33 | 21.65 | 433.7 | -100.81 | 454.39 | Upgrade
|
| Free Cash Flow Growth | - | -95.01% | - | - | 31.51% | Upgrade
|
| Free Cash Flow Margin | -0.86% | 0.51% | 12.25% | -3.24% | 14.71% | Upgrade
|
| Free Cash Flow Per Share | -0.02 | 0.02 | 0.31 | -0.07 | 0.33 | Upgrade
|
| Cash Income Tax Paid | - | 455.21 | 370.44 | 311.21 | 348.19 | Upgrade
|
| Levered Free Cash Flow | 702.49 | 123.24 | 464.92 | 245.79 | 293.18 | Upgrade
|
| Unlevered Free Cash Flow | 702.49 | 181.18 | 528.46 | 318.45 | 375.25 | Upgrade
|
| Change in Net Working Capital | -646.22 | -412.52 | -333.78 | -491.12 | -225.39 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.